Cargando…
Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571130/ https://www.ncbi.nlm.nih.gov/pubmed/37841932 http://dx.doi.org/10.3389/fphar.2023.1295784 |
| _version_ | 1785119916565725184 |
|---|---|
| author | Yi, Jia-Qin Huang, Sheng Wu, Miao-Juan Ma, Jie-Hui Huang, Li-Juan Liang, Song Sun, Dan |
| author_facet | Yi, Jia-Qin Huang, Sheng Wu, Miao-Juan Ma, Jie-Hui Huang, Li-Juan Liang, Song Sun, Dan |
| author_sort | Yi, Jia-Qin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10571130 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105711302023-10-14 Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy Yi, Jia-Qin Huang, Sheng Wu, Miao-Juan Ma, Jie-Hui Huang, Li-Juan Liang, Song Sun, Dan Front Pharmacol Pharmacology Frontiers Media S.A. 2023-09-29 /pmc/articles/PMC10571130/ /pubmed/37841932 http://dx.doi.org/10.3389/fphar.2023.1295784 Text en Copyright © 2023 Yi, Huang, Wu, Ma, Huang, Liang and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Yi, Jia-Qin Huang, Sheng Wu, Miao-Juan Ma, Jie-Hui Huang, Li-Juan Liang, Song Sun, Dan Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| title | Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| title_full | Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| title_fullStr | Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| title_full_unstemmed | Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| title_short | Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| title_sort | corrigendum: comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571130/ https://www.ncbi.nlm.nih.gov/pubmed/37841932 http://dx.doi.org/10.3389/fphar.2023.1295784 |
| work_keys_str_mv | AT yijiaqin corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy AT huangsheng corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy AT wumiaojuan corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy AT majiehui corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy AT huanglijuan corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy AT liangsong corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy AT sundan corrigendumcomparisonoftheeffectivenessandsafetyofperampanelandoxcarbazepineasmonotherapyinchildrenandadolescentswithnewlydiagnosedfocalepilepsy |